These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21368891)

  • 1. Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease.
    Crews L; Patrick C; Adame A; Rockenstein E; Masliah E
    Cell Death Dis; 2011 Feb; 2(2):e120. PubMed ID: 21368891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity.
    Chen J; Li S; Sun W; Li J
    PLoS One; 2015; 10(4):e0123864. PubMed ID: 25875370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease.
    Sadleir KR; Vassar R
    J Biol Chem; 2012 Mar; 287(10):7224-35. PubMed ID: 22223639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxiredoxin 5 Decreases Beta-Amyloid-Mediated Cyclin-Dependent Kinase 5 Activation Through Regulation of Ca
    Park J; Kim B; Chae U; Lee DG; Kam MK; Lee SR; Lee S; Lee HS; Park JW; Lee DS
    Antioxid Redox Signal; 2017 Oct; 27(11):715-726. PubMed ID: 28358580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
    Shi C; Viccaro K; Lee HG; Shah K
    J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
    Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
    Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the prefrontal cortex after the hippocampus was injected with Aβ
    Wang Y; Sheng H; Zhao J; Guo L; Liu J; Xu J; Liu Q; Huang J; Jiang R; Gan S; Qiu G; Lu W; Xu S; Zhu S
    Neurosci Lett; 2021 Jan; 741():135453. PubMed ID: 33186609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient enhancement of proliferation of neural progenitors and impairment of their long-term survival in p25 transgenic mice.
    Zou D; Zhou Y; Liu L; Dong F; Shu T; Zhou Y; Tsai LH; Mao Y
    Oncotarget; 2016 Jun; 7(26):39148-39161. PubMed ID: 27283769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β Fosters p35/CDK5 Signaling Contributing to Changes of Inhibitory Synapses in Early Stages of Cerebral Amyloidosis.
    Kiss E; Groeneweg F; Gorgas K; Schlicksupp A; Kins S; Kirsch J; Kuhse J
    J Alzheimers Dis; 2020; 74(4):1167-1187. PubMed ID: 32144981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity.
    Wilkaniec A; Gąssowska-Dobrowolska M; Strawski M; Adamczyk A; Czapski GA
    J Neuroinflammation; 2018 Jan; 15(1):1. PubMed ID: 29301548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
    Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
    Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
    Lopes JP; Oliveira CR; Agostinho P
    Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
    Crews L; Rockenstein E; Masliah E
    Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
    Shukla V; Skuntz S; Pant HC
    Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1).
    Giusti-Rodríguez P; Gao J; Gräff J; Rei D; Soda T; Tsai LH
    J Neurosci; 2011 Nov; 31(44):15751-6. PubMed ID: 22049418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of Cdk5 activator p35 in social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit in the transgenic mice.
    Hsiao YH; Chen PS; Chen SH; Gean PW
    Neuropsychopharmacology; 2011 Aug; 36(9):1848-58. PubMed ID: 21544067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
    Qin X; Wang Y; Paudel HK
    Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing.
    Posada-Duque RA; López-Tobón A; Piedrahita D; González-Billault C; Cardona-Gomez GP
    J Neurochem; 2015 Jul; 134(2):354-70. PubMed ID: 25864429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
    Lopes JP; Oliveira CR; Agostinho P
    Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.